These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7078638)

  • 61. Effect of toxin-antibody conjugates on tumor cells.
    Uhr JW
    Cell Immunol; 1982 Jan; 66(1):24-8. PubMed ID: 7044565
    [No Abstract]   [Full Text] [Related]  

  • 62. Tumor-specific immune responses and opportunities for tumor vaccines.
    Finn OJ
    Clin Immunol Immunopathol; 1994 Jun; 71(3):260-2. PubMed ID: 8200128
    [No Abstract]   [Full Text] [Related]  

  • 63. Humoral effector mechanisms in the immunity to cancer.
    George AJ; Stevenson FK
    Immunol Today; 1990 Oct; 11(10):348-9. PubMed ID: 2222758
    [No Abstract]   [Full Text] [Related]  

  • 64. Liposomes as aids to tumour detection.
    Barratt GM; Ryman BE; Chester KA; Begent RH
    Biochem Soc Trans; 1984 Apr; 12(2):348-9. PubMed ID: 6724123
    [No Abstract]   [Full Text] [Related]  

  • 65. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
    Schulz G; Bumol TF; Reisfeld RA
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5407-11. PubMed ID: 6577434
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fc gamma receptor antibodies.
    Karpovsky B; Titus JA; Stephany DA; Segal DM
    J Exp Med; 1984 Dec; 160(6):1686-701. PubMed ID: 6239899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma.
    Eisenthal A; Rosenberg SA
    Clin Exp Metastasis; 1988; 6(5):387-400. PubMed ID: 3378376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Presence in mouse bone marrow of mediator-dependent cytotoxic effector cells against tumors.
    Nakajima-Masuko Y; Okutomi T; Abe S; Mizuno D; Yamazaki M
    Jpn J Exp Med; 1983 Oct; 53(5):227-33. PubMed ID: 6689597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neutrophil--mediated cytotoxicity against tumour cells: state of art.
    Dallegri F; Ottonello L
    Arch Immunol Ther Exp (Warsz); 1992; 40(1):39-42. PubMed ID: 1362490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of antibodies in the specificity of natural cell-mediated cytotoxicity.
    Takasugi M; Akira D
    J Natl Cancer Inst; 1979 Jun; 62(6):1361-5. PubMed ID: 286107
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induction of polymorphonuclear leukocyte-mediated cytolysis by wheat germ agglutinin and antitumor antibody.
    Tsunawaki S; Oshima H; Mizuno D; Yamazaki M
    Gan; 1983 Apr; 74(2):258-64. PubMed ID: 6862146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Directed effector cells selectively lyse human tumour cells.
    Simone CB
    Nature; 1982 May; 297(5863):234-6. PubMed ID: 7078638
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.